Skip to content

Author

Y. Koubi

We have 1 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

QSAR Modeling, In-silico ADMET, Molecular Docking, Biological Efficacy and Retrosynthesis: Study of Potential Anti-cancer Agents with Inhibitory Effect on Liver Cancer Stem Cells

Pr3 has a higher effectiveness in treating liver cancer when compared to the other compounds, emerges as a promising hit candidate for further experimental investigation and Lipinski characteristics and synthetic accessibility coefficient suggest their potential for therapeutic use.

Y. Moukhliss, Y. Koubi, L. Naanaai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.